Abstract

The pharmaceutical industry is subject to numerous regulations and guidelines aimed at ensuring the safety and efficacy of drugs. Navigating the complex landscape of regulatory compliance can be challenging for companies operating in this industry. This article discusses some of the key challenges faced by pharmaceutical companies in regulatory compliance, including pharmacovigilance and counterfeit drugs. It then provides possible ways to address several of these challenges, such as implementing a robust pharmacovigilance system, strengthening supply chain management, and increasing public awareness. The article highlights the importance of staying updated with regulations, maintaining accurate documentation, and collaborating with stakeholders to ensure regulatory compliance. By adopting these measures, pharmaceutical companies can navigate the complex landscape of regulatory compliance and ensure the safety and efficacy of their products.

Keywords:Regulatory compliance; Pharmaceutical companies; Public health; Pharmacovigilance; Drugs